Fredag 5 September | 13:12:11 Europe / Stockholm
Svenska | English

Västra Hamnen Market Focus

Prenumeration

Gabather: TOTEMS-study delayed, not derailed
2025-09-01 12:00:00
  • Issues with clinical test material delays TOTEMS-study
  • New chairman elected at the AGM
  • We keep our fair value of SEK 0.092 per share

Before releasing its Q2 2025 report, Gabather announced that the TOTEMS-study would be delayed due to issues with the clinical trial material. Meanwhile, changes have taken place in the company’s board, with a new chairman being elected. Despite challenges, we maintain our fair value of SEK 0,092 per share.

The full report is available here.

About Market Focus

The research report is prepared as part of Market Focus, Västra Hamnen Corporate Finance's commissioned research offering.

This is a press release from Västra Hamnen Corporate Finance AB. 
Web: vhcorp.se
Twitter: @vhcorp_se (https://x.com/vhcorp_se)

Källa MFN
Enter your email address and you will get a mail for verification you subscription to content on this page and filter


Select the time zone location for site wide time

Europe
London
Oslo
Stockholm
Helsinki

America
New York / Eastern
Chicago / Central
Los Angeles / Western

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden